基本信息
浏览量:21
职业迁徙
个人简介
Jeffry Weers is currently the Chief Technology Officer at cystetic Medicines, Inc. cystetic Medicines is focused on development of a novel genotype independent therapeutic that restores anion transport in people with cystic fibrosis caused by Class 1 and other rare mutations for which there are currently no targeted therapies. He is a physical chemist with a Ph.D. in Chemistry from the University of California, Davis.
Jeff has spent the last 25 years of his career focused on the design of formulations and devices for respiratory drug delivery. In this regard he has worked for numerous companies including Alliance Pharmaceutical Corp., Inhale Therapeutic Systems (now Nektar Therapeutics), Transave, Inc. (now Insmed), Novartis Pharmaceutical Corp., and Respira Therapeutics.
Jeff has published more than 100 peer reviewed papers (h-index = 52), has authored several book chapters, and spoken at many national and international meetings. He is a prolific inventor with nearly 300 issued patents worldwide. Jeff’s inventions include a blood substitute (Oxygent™), an ultrasound contrast agent (Imagent®), a ventilation technique termed partial liquid ventilation (LiquiVent®), a hydrogel to prevent post-operative adhesions (FloGel®), and numerous patents related to engineered particles for inhalation (e.g., the PulmoSphere™ technology) which is utilized in inhaled drug products including TOBI® Podhaler™, Bevespi® Aerosphere, Breztri® Aerosphere and Ciprofloxacin DPI. Patents are also directed to aerosol delivery of antiinfectives utilizing combinations of liposome encapsulated and free drug (e.g., Arikayce®).
Jeff has received numerous awards including RDD’s Charles G. Thiel Award and the Alexander Fleming Serendipity Award from the London Business School. He is a Fellow of AAPS, an Associate Editor for Frontiers in Drug Delivery and serves on the Editorial Board of the J Aerosol Med Pulm Drug Deliv.
研究兴趣
论文共 175 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Expert Opinion on Drug Deliveryno. 3 (2024): 365-380
A. Lewandowska,I. Thornell, C. Soutar, K. Green, J. Marin-Toledo, Y. Shelke, D. Miller,T. Tarara,T. Pogorelov,C. Rienstra, M. Welsh,J. Weers, M. Burke
Journal of Cystic Fibrosis (2023): S142-S143
Journal of Cystic Fibrosis (2023): S129
A. Lewandowska,I. Thornell, C. Soutar, K. Green, J. Lange,D. Miller,T. Tarara,T. Pogorelov,C. Rienstra, M. Welsh,J. Weers,M. Burke
Thomas E. Tarara,Danforth P. Miller, Audrey E. Weers,Ariel Muliadi,Jerry Tso,Avi Eliahu,Jeffry G. Weers
Frontiers in drug delivery (2022)
Frontiers in drug delivery (2022)
Sandra Anderson, Paul Atkins,Per Bäckman,David Cipolla,Andrew Clark,Evangelia Daviskas,Bernd Disse, Plamena Entcheva-Dimitrov,Rick Fuller,Igor Gonda,Hans Lundbäck,Bo Olsson,Jeffry Weers
Pharmacological reviewsno. 1 (2022): 48-118
加载更多
作者统计
#Papers: 175
#Citation: 7573
H-Index: 47
G-Index: 81
Sociability: 6
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn